Certain avant-garde works of art, wine and even people can sometimes take years to come into their own. The same can be true of inventions, and likewise, patents. That time may have finally arrived for Crossroads Systems, Inc. ("Crossroads") (CRDS). After pursuing scores of patent litigations going back more than a decade, which have resulted in numerous settlements, but only modest revenue, the sudden widespread commercialization of Crossroads' inventions may have finally matured to a point that will open the doors to significant, share-price-shifting patent-licensing revenue. Crossroads' decade-old patent-monetization campaign may be about to come of age.
At Markman Advisors, we are seasoned patent litigation attorneys who are all registered patent-attorneys with the United States Patent and...
Only subscribers can access this article, which is part of the PRO research library covering 3,612 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: